U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07147127) titled 'Anti-citrullinated SR-A Peptide (Anti-csp) Antibody as a Biomarker in Rheumatoid Arthritis (RA).' on Aug. 09.
Brief Summary: 1. To measure serum level of anticitrullinated SR-A peptide antibody (anti-CSP) in RA patients compared to healthy controls .
2. To assess the diagnostic performance of anti-CSP for RA specifically seronegative RA patients.
3. To evaluate correlation of serum anti-CSP level with disease activity and functional disability scores in RA patients.
Study Start Date: Jan., 2026
Study Type: OBSERVATIONAL
Condition:
Rheumatoid Arthritis (RA)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Walaa sharif Eid Ahme...